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Abstract
Background: Interleukin-1B (IL-1B) is a key pro-inflammatory cytokine that has been associated with the development of
atherosclerosis and myocardial infarction. However, the prospective associations between functional single nucleotide
polymorphisms (SNPs) in IL1B and incident acute coronary syndrome (ACS) have not been thoroughly investigated. The
aims of this study were to examine the associations between individual SNPs in and SNP haplotypes of the promoter region
of IL1B and incident ACS in a prospective study. Furthermore, we wanted to explore potential interactions with other risk
factors for ACS on an additive scale.
Methodology/Principal Findings: The present study was based on the Danish prospective study Diet, Cancer and Health
comprising more than 57 000 participants aged 50–64 at baseline. During a median follow-up of 7.2 years we identified 989
cases of incident ACS (755 men and 234 women). All cases were validated by review of medical records, and information on
covariates was collected by study technicians. The study was conducted according to a case-cohort study design including
ACS cases and a sex-stratified sub cohort of 1663 participants drawn randomly from the entire cohort. Weighted Cox
proportional hazard models with age as time axis were used in the statistical analyses. Individual IL1B SNPs, SNP haplotypes,
or haplotype combinations were not significantly associated with incident ACS, and, likewise, we found no evidence of
interaction on an additive scale between IL1B haplotypes and risk factors, respectively.
Conclusions/Significance: Genetic variation in the promoter region of IL1B may not be associated with incident ACS in men
or women above the age of 50 years.
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Introduction
Interleukin-1B (IL-1B) is a key pro-inflammatory cytokine that
induces the production of other cytokines, adhesion molecules,
and metalloproteinases [1,2]. The IL-1 signaling pathway has
been associated with the development of atherosclerosis in animal
studies[3–5], and IL-1B mRNA is increased in human atheroscle-
rotic arteries [6]. In a human case-control study, the -511T single
nucleotide polymorphism (SNP) in IL1B was associated with a
lower release of IL-1B from human mononuclear cells and a
relatively low risk of myocardial infarction at young age [7]. Thus,
IL1B expression by itself may influence the inflammatory processes
in the arterial wall that lead to the development of atherosclerotic
plaques and acute coronary syndrome(ACS)[8–10]. Furthermore,
IL1B polymorphisms may interact with obesity, as the effect of
obesity on plaque development is partly mediated by the release of
inflammatory cytokines from adipose tissue compartments [11].
Likewise, the IL1B -3737T polymorphism modifies a binding site
for the anti-inflammatory p50 subunit of the NF-kB transcription
factor family [12], and thus there may be interaction between the
IL1B -3737T genotype and the NFKB1 -94 ATTG ins/del
polymorphism which modifies the protein level of the p50 subunit
and by itself is positively associated with the risk of ACS [13].
The entire IL1B gene has been sequenced, and several SNPs
have been identified in the promoter region, but only four (T-
31C, C-511T, G-1464C, and C-3737T) seem to be interesting
regarding prevalence and functionality [12]. However, T-31C
and C-511T are in complete linkage in Danes [14], leaving
three functional polymorphisms in this population. The SNPs
are all located in the same promoter region, and to address the
combined effects of concurrent SNPs, we also performed
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human genome.
The aims of this study were to examine the primary associations
between individual SNPs as well as SNP haplotypes and haplotype
combinations in IL1B and incident ACS in a prospective study.
Furthermore, we wanted to explore the potential interaction with
obesity and the NFKB1 -94 ATTG ins/del polymorphism,
respectively. We hypothesized that SNPs and SNP haplotypes
associated with higher levels of IL-1B expression would be
positively associated with the incidence of ACS. Likewise, we
hypothesized that the combined effect of SNP haplotypes
associated with higher levels of IL-1B expression and obesity
would be additive or greater.
Materials and Methods
Study Population
The present study was based on the Danish prospective study
Diet, Cancer and Health, which has previously been described in
detail [15]. In brief, from November 1993 to May 1997, all men
and women aged 50–64 years, born in Denmark, and with no
previous cancer diagnosis registered in the Danish Cancer Registry
were invited to participate in the study. The Diet, Cancer and
Health study was approved by the National Committee on Health
Research Ethics (journal nr. (KF) 01-345/93) and the Danish Data
Protection Agency. Written informed consent was obtained from
all participants to search information from medical registers.
A total of 80 996 men and 79 729 women were invited to
participate in Diet, Cancer and Health, and 27 178 men (34%)
and 29 875 women (37%) consented to participate. During a
median follow up of 7.2 years, 872 male and 272 female cases of
incident ACS were diagnosed. To preserve biological material the
present study was conducted as a case-cohort study and
genotyping was only performed on cases and participants in a
sex-stratified subcohort initially comprising 1869 participants
drawn randomly from the entire cohort ultimo 2003.
We excluded 1011 participants with prevalent ACS, and 564
participants who, due to delay in the Danish Cancer Registry,
were erroneously included in Diet, Cancer and Health, as they
had been diagnosed with cancer before inclusion. Furthermore, we
excluded 460 participants for whom information on exposure or
confounder variables were missing. After exclusions there were
755 male and 234 female cases of incident ACS, and the subcohort
consisted of 887 men and 776 women. The subcohort included
32 participants (26 men and 6 women) who later became cases.
Genotyping
DNA was isolated from frozen lymphocytes as previously
described [16–18]. The IL1B T-31C (rs1143627), IL1B
G21464C (rs1143623), and IL1B C23737T (rs4848306) geno-
types were determined on an ABI 7900HT using allelic
discrimination (Applied Biosystems, Birkerød, Denmark) as
previously described [14,16].
Genotypes of NFKB1 ATTG ins/del (rs28362491) were
determined by Taqman allelic discrimination (ABI 7500, Applied
Biosystems) [19]. Controls with known genotypes were included in
each run, and repeated genotyping of 10% of the samples yielded
identical results. Cases and controls were mixed during genotyping
and the case status of samples was blinded during genotyping.
Endpoint
The endpoint was incident ACS (International Classification of
Disease (ICD) 8: 410–410.99 or ICD 10: I20, I21.0–I21.9), and
potential cases were identified by linkage with the Danish National
Patient Registry and the Danish Causes of Death Registry using
the Danish Civil Registration System in which every Danish
person is identified by a unique 10-digit number. The Danish
National Patient Registry [20] holds information on diagnoses and
procedures (e.g. percutaneous coronary intervention) in relation to
all hospital ward admissions since 1977, while all visits at
outpatient clinics and emergency rooms have been registered
since 1995. The Danish Causes of Death Registry includes all
deaths since 1943. Patients were registered in both registries in
accordance with ICD 8 until January 1
st 1995 and subsequently
according to ICD 10.
Potential cases of incident ACS in Diet, Cancer and Health
were validated by review of medical records and classified in
accordance with the guidelines of the American Heart Association
and the European Society of Cardiology for use in epidemiology
[21]. Genetic or anthropometric data were not available at the
time of case validation.
Covariates
Anthropometric data were obtained by trained laboratory
technicians. Height was measured to the nearest 0.5 cm with the
participants standing without shoes. Weight was measured using a
digital scale with the participants wearing light clothing and
recorded to the nearest 0.1 kg. Waist circumference was recorded
to the nearest 0.5 cm and measured at the narrowest part between
the lower rib and the iliac crest. Information on other potential
confounders was obtained through questionnaires covering socio-
demographic factors, lifestyle, and general health including
prevalent diseases and medications.
Statistical Methods
In accordance with the case-cohort design and to allow for
delayed entry of the participants, the hazard ratios (HR) of
incident ACS were estimated by weighted Cox proportional
hazards regression models with age as the underlying time variable
[22,23]. The observation time was censored by death from other
causes than ACS, emigration, or study end. The proportionality
assumptions of the Cox proportional hazards models were
evaluated graphically using log-log plots.
The distribution of obesity (waist circumference (WC), hip
circumference (HC), and body mass index (BMI)) was described in
accordance with the WHO classification, but analyses reported in
tabulations were based on three categories according to the
distribution among cases. WC and HC were described by splines
when included as covariates. We adjusted for potential confound-
ing from educational level (basic school, higher education 1–3
years, or higher education .3 years), smoking status (non-smoker,
current ,15, or $15 g/d), alcohol intake (spline), hypertension
(yes, no, or unknown), diabetes mellitus (yes, no, or unknown),
hypercholesterolemia (yes, no, or unknown). For women we also
included menopausal status (pre, post, or unknown). Hypertension,
hypercholesterolemia, and diabetes mellitus were not included in
analyses with anthropometric exposure variables, as they are
intermediate variables in these analyses. The ‘‘unknown’’ category
refers to participants who had provided information, but could not
be defined as ‘‘yes’’ or ‘‘no’’. All splines were centered restricted
cubic splines with three knots placed as suggested by Harrel [24].
Potential biological interaction on an additive scale between
SNP haplotypes and obesity (BMI, WC adjusted for HC, HC
adjusted for WC) or the NFKB1 -94 ATTG ins/del polymorphism
was explored as the relative excess risk due to interaction (RERI)
and calculated as suggested by Rothman [25].
Due to the difference in biology and prevalence of ACS between
the sexes, we performed separate analyses in men and women.
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conducted combined-sex analyses. All analyses were performed
using Stata version 11.2 (StataCorp. 2009. Stata Statistical Software:
Release 11. College Station, TX: StataCorp LP).
Results
Baseline characteristics of the participants are presented in
Table 1. Compared to the subcohort, both male and female cases
appeared on average older, drank less alcohol, and fewer were
never smokers. Similarly, cases had a higher prevalence of
Table 1. Baseline characteristics of the subcohort and cases of incident acute coronary syndrome.
Men Women
Subcohort Cases Subcohort Cases
Variable (n=887) (n=755) (n=776) (n=234)
Age 56.0 (51.3;63.4) 57.9 (51.7;64.1) 55.8 (51.0;62.7) 59.9 (52.4;64.2)
Postmenopausal n/a n/a 58.1% 71.1%
Educational level
Basic school 10.4% 14.8% 21.7% 31.5%
Higher education 1–3 years 13.4% 17.4% 31.2% 33.2%
Higher education .3 years 76.0% 67.8% 47.2% 35.3%
Smoking status
Non-smoker 61.6% 40.7% 63.5% 41.3%
Less than 15 g/d 10.5% 12.5% 15.5% 24.3%
More than 15 g/d 28.0% 46.9% 21.0% 34.5%
Alcohol (g/day) 20.0 (3.1,61.6) 17.3 (2.0;61.2) 8.8 (1.0;34.4) 6.0 (0.7;32.6)
Hypertension
1 13.40% 22.1% 16.0% 38.7%
Diabetes mellitus
1 2.5% 5.3% 1.0% 5.1%
Hypercholesterolemia
1 9.6% 12.3% 5.9% 17.5%
Body Mass Index (kg/m
2) 26.4 (22.5;31.1) 27.0 (23.3;32.3) 24.6 (21.0;30.6) 26.3 (21.4;32.6)
BMI grouped according to WHO
Underweight 0.3% 0.1% 1.3% 1.3%
Normalweight 33.8% 26.6% 53.0% 37.9%
Overweight 50.5% 51.1% 33.3% 38.3%
Obese 15.3% 22.1% 12.5% 22.6%
Waist circumference (cm) 95.0 (84.0;108.0) 97.0 (87.0;112.0) 80.0 (69.0;97.0) 86.0 (71.0,101.0)
Hip circumference (cm) 100.0 (92.5;108.0) 101.0 (93.0;110.0) 100.5 (92.0;113.0) 102.0 (91.0;114.0)
NFKB1 94ATTG ins/del polymorphism
Wildtype/Wildtype 40% (358) 35% (265) 37% (291) 38% (90)
Wildtype/Variant 45% (403) 48% (360) 47% (364) 46% (108)
Variant/Variant 14% (126) 17% (130) 16% (121) 15% (36)
Medians with 10th and 90th percentiles in brackets for continuous variables. Percentages for discrete variables. Diet, Cancer and Health, Denmark, 1993–2003.
1)Self-reported.
doi:10.1371/journal.pone.0036829.t001
Table 2. Display of the 4 haplotypes describing more than 99% of the genotype combinations.
Haplotype
Polymorphisms 1 2 3 4
IL1B C23737T C (wildtype) T (variant) C (wildtype) C (wildtype)
IL1B G21464C G (wildtype) G (wildtype) C (variant) G (wildtype)
IL1B T-31C T (wildtype) T (wildtype) C (variant) C (variant)
IL1B promotor activity (Chen et al
1) Low Medium Medium High
Diet, Cancer and Health, Denmark, 1993–2003.
1)Chen H et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 2006 Feb
15;15(4):519–529.
doi:10.1371/journal.pone.0036829.t002
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baseline. More cases were overweight or obese, and overall few
were underweight according to the WHO classification.
Haplotypes were inferred manually, and we identified 4
haplotypes which described more than 99.9% of the genotype
combinations (Table 2). The haplotypes were identical to previous
findings in Caucasians [12]. All genotypes were in Hardy-
Weinberg equilibrium (data not shown), and the minor allele
frequencies were similar among men and women (Table 3).
Haplotype 1 included the wildtype allele of all three SNPs
(Table 2), but more participants were homozygote for haplotype 2
than haplotype 1 (Table 4). Thus, participants with haplotype
combination 22 were used as reference group in the analyses.
We did not find any significant associations between the
individual SNPs and incident ACS (Table 3) among men or
women, and analyses of both sexes combined yielded very precise
neutral estimates. Likewise, none of the individual haplotypes or
haplotype combinations showed significant associations with ACS
(Table 4).
When we investigated the combined effect of SNP haplotypes 1,
2 and, 3 and obesity (BMI, WC adjusted for HC, HC adjusted for
WC) or the NFKB1 -94 ATTG ins/del polymorphism, the results
showed no indication that haplotype carrier status modified the
effect of the investigated variable. Cross tabulations are presented
in an online supplement (Table S1 and Table S2). The prevalence
of haplotype 4 was low, and thus haplotype 4 was omitted from the
interaction analyses.
Discussion
In this large prospective study, we found no significant
associations between individual SNPs or SNP haplotypes in the
Table 3. Cox proportional hazard ratios (HR) with 95% confidence interval in brackets for the association between single
nucleotide polymorphisms in IL1B and incident acute coronary syndrome.
MEN WOMEN ALL
n Crude Adjusted
1 n Crude Adjusted
1 Crude
2 Adjusted
2
Polymorphism Subcohort Cases HR HR Subcohort Cases HR HR HR HR
IL1B C23737T
Wildtype/
Wildtype
31% (279) 31%
(233)
1 (ref.) 1 (ref.) 33% (259) 29% (69) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Wildtype/Variant 49% (437) 48%
(359)
0.96 (0.77;1.21) 0.90 (0.70;1.16) 47% (365) 53% (125) 1.24
(0.88;1.76)
1.24 (0.82;1.89) 1.02
(0.84;1.24)
0.96
(0.78;1.19)
Variant/Variant 19% (171) 22%
(163)
1.09 (0.82;1.45) 1.04 (0.76;1.42) 20% (152) 17% (40) 1.00
(0.64;1.58)
1.11 (0.67;1.84) 1.07
(0.84;1.37)
1.03
(0.79;1.35)
Dominant variant
model
– – 1.00 (0.81;1.24) 0.94 (0.74;1.19) – – 1.17
(0.84;1.63)
1.21 (0.82;1.78) 1.04
(0.87;1.24)
0.98
(0.81;1.20)
Minor allele
frequency
44% – – – 43% – – – – –
IL1B G21464C
Wildtype/
Wildtype
54% (477) 53%
(399)
1 (ref.) 1 (ref.) 52% (401) 53% (124) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Wildtype/Variant 39% (348) 40%
(299)
1.03 (0.84;1.27) 1.04 (0.83;1.31) 40% (310) 41% (97) 1.01
(0.73;1.39)
0.86 (0.59;1.24) 1.03
(0.86;1.23)
1.00
(0.82;1.22)
Variant/Variant 7% (62) 8% (57) 1.13 (0.77;1.68) 1.10 (0.71;1.69) 8% (65) 6% (13) 0.73
(0.38;1.39)
0.69 (0.33;1.44) 1.03
(0.74;1.43)
1.02
(0.71;1.47)
Dominant variant
model
– – 1.05 (0.86;1.28) 1.05 (0.84;1.30) – – 0.97
(0.71;1.31)
0.83 (0.58;1.19) 1.03
(0.87;1.22)
1.00
(0.83;1.21)
Minor allele
frequency
27% – – – 28% – – – – –
IL1B T–31C
Wildtype/
Wildtype
45% (397) 47%
(352)
1 (ref.) 1 (ref.) 44% (341) 44% (104) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Wildtype/Variant 44% (390) 43%
(321)
0.94 (0.76;1.16) 0.95 (0.75;1.19) 45% (345) 47% (109) 1.00
(0.73;1.39)
0.83 (0.57;1.20) 0.96
(0.80;1.14)
0.92
(0.76;1.12)
Variant/Variant 11% (100) 11%
(82)
1.02 (0.73;1.42) 1.04 (0.73;1.50) 12% (90) 9% (21) 0.87
(0.50;1.50)
0.80 (0.44;1.48) 0.98
(0.74;1.31)
1.01
(0.74;1.38)
Dominant variant
model
– – 0.96 (0.78;1.17) 0.96 (0.77;1.20) – – 0.98
(0.72;1.33)
0.82 (0.58;1.17) 0.96
(0.81;1.14)
0.94
(0.78;1.13)
Minor allele
frequency
33% – – – 34% – – – – –
Median follow up 7.2 years. Diet, Cancer and Health, Denmark, 1993–2003.
1)Age used as time axis. Adjusted for educational level, waist circumference, smoking status, alcohol consumption, hypertension, diabetes mellitus and
hypercholesterolemia. Women also adjusted for menopausal status.
2)Also adjusted for sex.
doi:10.1371/journal.pone.0036829.t003
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PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e36829promoter region of the IL1B gene and incident ACS. Further-
more, we found no evidence that the investigated SNP haplotypes
modified the effect of obesity on the risk of ACS. Confidence limits
show that it is quite unlikely that a possible true association could
have given rise to the estimates.
The biological effect of the investigated SNPs on IL1B
expression [12] and release of IL-1B [7] is well established, and
the lack of statistically significant associations in our study suggests
that IL-1B may have a limited role in the development of ACS in
men and women above the age of 50.
The potential for selection bias during follow-up was limited as
the proportion lost to follow-up was very small. We achieved a
high level of data ascertainment, as all cases were validated by
direct review of medical records and data on anthropometric
variables were collected by trained study technicians according to
a standardized protocol. Due to the subtle nature of atheroscle-
rosis, reverse causation is a possibility in the anthropometry
analyses, but we have previously found similar associations for all
anthropometric variables when conducting analyses in participants
who experienced an event within the first two years of follow-up
and in participants who experienced an event after more than two
years of follow-up [26].
There are several risk factors for ACS, and though these
covariates may not be causally correlated with the genetic
exposure variables, they may still be unevenly distributed among
exposed and unexposed due to chance. However, adjustment for
confounding had only limited effect on the associations suggesting
that residual confounding was unlikely to play a major role for our
findings.
The interpretation of the analyses of individual SNPs has been
extensively discussed in the literature [12,27], but it still seems
reasonable to investigate functional SNPs in relevant genes if the
minor allele frequency is high. In case of a significant association,
further investigation may reveal whether the association is due to
an isolated effect of the investigated SNP or a haplotype marked
by the SNP. In the present study, we investigated 3 SNPs in the
same promoter region, and, as expected, the SNPs were tightly
linked, and thus only four haplotypes included more than 99.9%
of the genotypes. The C-3737T and G-1464C SNPs were each
present on only one haplotype which explains the almost identical
results concerning C-3737T and haplotype 2 and G-1464C and
haplotype 3, respectively (Table 3 and 4). Likewise, it is
noteworthy that the variant C allele of the G-1464C SNP was
only present in haplotype 3 which also included the variant C
allele of the T-31C SNP, and thus, the isolated associations for the
G-1464C SNP could not be examined in our cohort. The T-31C
SNP was present on both haplotype 3 and 4, and thus,
homozygote variant -31C carriers may be either homozygote for
haplotype 3 or haplotype 4 or be heterozygote and carry both
haplotype 3 and 4. This demonstrates a key problem in the
analysis of individual SNPs, as analysis of the T-31C SNP will be
affected by the presence of G-1464C among some, but not all, of
the variant -31C carriers.
The identified haplotypes and their distribution were similar
to the results of Chen et al [12], who found that haplotype 1
(all wildtype alleles) had the lowest transcriptional activity in
response to LPS. Both haplotype 2 and 3 showed higher
activity than haplotype 1, but their activities were not
significantly different, whereas haplotype 4 showed the highest
activity (Table 2). However, Chen et al only investigated
individual haplotypes and not haplotype combinations as they
are present in human genome, and thus the combined effect of
haplotypes, e.g. haplotype 1 on the maternal allele and
haplotype 2 on the paternal allele, is not clear. We expected
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PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e36829a stepwise higher risk of ACS from haplotype combination 11
(lowest IL1B activity) through haplotype combinations 22 and
33 up to haplotype combination 44 (highest IL1B activity) if
IL1B activity was associated with ACS, but this could not be
demonstrated (Table 4). The associations for the discordant
haplotype combinations could not be predicted, and we found
no statistically significant associations for any of them.
Iacoviello et al found that the variant allele of the C-511T SNP,
and relatively low IL-1B, was protective against myocardial
infarction at young age [7]. Based on the same study population,
Latella et al observed a similar reduced risk of myocardial
infarction at young age for participants carrying haplotypes
containing the variant -511T SNP [28]. In Danes, the C-511T
SNP is in complete linkage disequilibrium with C-31T [14], and
thus both haplotype 3 and 4 in our study must contain the variant
allele of the C-511T SNP. This is in line with the fact that the
inferred haplotypes in the study by Latella et al were identical to
the haplotypes determined in our study, given that the C-31T and
the C-511T SNPs are in complete linkage disequilibrium.
However, we found no evidence of a consistent significant
association between incident ACS and either the T-31C SNP or
haplotype 3 or 4 (Table 3 and Table 4). This could be due to a
‘‘healthy participant effect’’ since the participants in our study
were at least 50 years of age at inclusion, and we excluded all
participants with prevalent ACS. Participants who had ‘‘survived’’
until inclusion without sustaining ACS might have had a reduced
susceptibility to the IL1B SNPs.
In conclusion, genetic variation in the promoter region of the
IL1B may not be associated with incident ACS in men or women
above the age of 50.
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